ArticleBone marrow transplantation2014

Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.

M A Kharfan-Dabaja et al.PubMed ↗Publisher ↗

No numbers read from the abstract.